Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study (Q79150763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

20 March 2024

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551300

20 March 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

20 March 2024

1

Laura Havrilesky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

7

Andrew Berchuck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Hasnah Hamdan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jorge Leon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jeffrey Bell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gynecologic Oncology Group Study

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Laura Havrilesky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551300

20 March 2024

kathleen M. Darcy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551300

20 March 2024

Roger L. Priore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551300

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551300

20 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551300

full work available at URL

20 March 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.11.052

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Journal of Clinical Oncology

20 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

3814-3825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

20 March 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

p53 tumor-suppressor gene: clues to molecular carcinogenesis

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Introduction: p53--the first twenty years

20 March 2024

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

p53-induced apoptosis as a safeguard against cancer.

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Mechanisms of p53-induced apoptosis

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action

20 March 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Mechanisms of p53-mediated apoptosis

20 March 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The cellular response to p53: the decision between life and death

20 March 2024

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Role of p53 family members in apoptosis

20 March 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The p53 proto-oncogene can act as a suppressor of transformation

20 March 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The p53 tumour suppressor gene

20 March 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The dual role model for p53 in maintaining genomic integrity

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Twenty years of p53 research: structural and functional aspects of the p53 protein

20 March 2024

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Functions of the MDM2 oncoprotein

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Regulation of p53 stability

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Mechanisms of switching on p53: a role for covalent modification?

20 March 2024

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

An information-intensive approach to the molecular pharmacology of cancer.

20 March 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

20 March 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

20 March 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

20 March 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Quantification of p53 in epithelial ovarian cancer

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines

20 March 2024

29

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

20 March 2024

34

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

20 March 2024

35

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Use of Ranks in One-Criterion Variance Analysis

20 March 2024

42

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Nonparametric Estimation from Incomplete Observations

20 March 2024

43

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Regression Models and Life-Tables (with discussion)

20 March 2024

45

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

20 March 2024

46

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

mdm2: a bridge over the two tumour suppressors, p53 and Rb.

20 March 2024

47

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

20 March 2024

48

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

BRCA1 signals ARF-dependent stabilization and coactivation of p53.

20 March 2024

49

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

20 March 2024

50

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function

20 March 2024

51

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Chemotherapy-induced apoptosis in epithelial ovarian cancers

20 March 2024

52

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

20 March 2024

53

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

20 March 2024

56

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis

20 March 2024

58

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.052

20 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14551300%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference